Skip to main content
    D

    Delcath Systems Inc (DCTH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $14.04
    -0.60 (-4.10%)

    Market Cap: $487.17M

    Last updated: Oct 30, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(18/26)
    Avg Surprise
    -24.53%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.13 - $-0.01
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.22+67.6%
    60d ago$-0.22+67.6%
    30d ago$-0.21+66.3%
    7d ago$-0.21+66.3%
    Current$-0.07
    Revenue Consensus
    $26M
    Range$25M - $27M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.13
    Range$0.05 - $0.26
    4 analysts
    Revenue Consensus
    $28M
    Range$27M - $30M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.13---
    Sep 26EST
    		-$-0.07---
    Jun 26
    Reported Aug 6
    		$0.07N/A+143.75%Beat+0.0%
    Mar 26
    Reported May 7
    		$-0.03N/A+66.67%Beat-200.0%
    Dec 25
    Reported Feb 26
    		$-0.05$-0.06+16.67%Beat+54.5%
    Sep 25
    Reported Nov 4
    		$0.02N/A+122.22%Beat-66.7%
    Jun 25
    Reported Aug 6
    		$0.07$0.03+133.33%Beat+114.6%
    Mar 25
    Reported May 8
    		$0.03$0.03+15.38%Beat+106.7%
    Dec 24
    Reported Mar 6
    		$-0.11$0.01-1200.00%Miss+77.1%
    Sep 24
    Reported Nov 8
    		$0.06N/A+131.58%Beat+105.3%
    Jun 24
    Reported Aug 5
    		$-0.48$-0.34-41.18%Miss+17.2%
    Mar 24
    Reported May 14
    		$-0.45$-0.45+0.00%Beat+41.6%
    Dec 23
    Reported Mar 26
    		$-0.48$-0.51+5.88%Beat+44.2%
    Sep 23
    Reported Nov 13
    		$-1.14$-0.49-132.65%Miss-23.9%
    Jun 23
    Reported Aug 9
    		$-0.58$-0.66+12.12%Beat+50.8%
    Mar 23
    Reported May 22
    		$-0.77$-0.62-24.19%Miss+23.0%
    Dec 22
    Reported Mar 27
    		$-0.86$-0.73-17.81%Miss-24.6%
    Sep 22
    Reported Nov 8
    		$-0.92$-1.04+11.54%Beat+2.1%
    Jun 22
    Reported Aug 8
    		$-1.18$-1.01-16.83%Miss-22.9%
    Mar 22
    Reported May 10
    		$-1.00$-0.86-16.28%Miss+3.8%
    Dec 21
    Reported Mar 25
    		$-0.69$-1.01+31.68%Beat-15.0%
    Sep 21
    Reported Nov 9
    		$-0.94$-1.13+16.81%Beat+19.0%
    Jun 21
    Reported Aug 10
    		$-0.96$-1.06+9.43%Beat+49.5%
    Mar 21
    Reported May 11
    		$-1.04$-1.03-0.97%Miss+99.0%
    Dec 20
    Reported Mar 31
    		$-0.60$-1.09+44.95%Beat-100.2%
    Sep 20
    Reported Nov 11
    		$-1.16$-2.11+45.02%Beat-182.9%
    Jun 20
    Reported Aug 13
    		$-1.90$-2.00+5.00%Beat-2275.0%
    Mar 20
    Reported May 14
    		$-108.07$-108.07+0.00%Beat-98145.5%
    Dec 19
    Reported Mar 25
    		$269.30N/AN/ABeat+158511.8%
    Sep 19
    Reported Nov 14
    		$-0.41N/AN/ABeat-64.0%
    Jun 19
    Reported Jul 17
    		$-0.08N/AN/ABeat+98.9%
    Mar 19
    Reported Jun 14
    		$-0.11N/AN/ABeat-101.0%
    Dec 18
    Reported Mar 13
    		$-0.17N/AN/ABeat+100.0%
    Sep 18
    Reported Nov 13
    		$-0.25N/AN/ABeat+100.0%
    Jun 18
    Reported Aug 15
    		$-7.26N/AN/ABeat+99.5%
    Mar 18
    Reported May 10
    		$10.91N/AN/ABeat+100.0%
    Dec 17
    Reported Mar 16
    		$-380.17N/AN/ABeat+100.0%
    Sep 17
    Reported Nov 14
    		$-4493.76N/AN/ABeat-
    Jun 17
    Reported Aug 8
    		$-1347.43N/AN/ABeat-
    Mar 17
    Reported May 9
    		$-43922.48N/AN/ABeat-
    Dec 16
    Reported Mar 29
    		$-1000000.00N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio1404.00EV/EBITDAN/A
    Price/FCF28.78xFCF Yield3.47%
    Profitability
    Profit Margin0.56%Operating Margin8.22%
    ROE0.47%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.83xQuick Ratio8.95x
    Trading Statistics
    Beta0.60Avg Volume308.93K
    52-Week High$17.4252-Week Low$8.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.58
    SMA 20$14.87
    SMA 50$15.66
    SMA 200$12.34
    EMA 10$14.60
    EMA 20$14.85
    EMA 50$15.06
    EMA 200$13.26

    MACD

    Line: -0.32Signal: -0.30Hist: -0.02

    ADX

    ADX: 23.2+DI: 14.8-DI: 25.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$13.91

    Bollinger Bands

    Upper Band$15.87
    Lower Band$13.88
    %B Position1339%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    37.3

    Momentum Oscillators

    Stoch %K30.6
    Stoch %D37.5
    Williams %R-93.0
    ROC (10d)-0.3%
    Momentum-0.04
    CCI (20d)-94.7
    MFI (14d)49.9

    Volatility Measures

    ATR (14d)$0.55(3.9%)
    StdDev (20d)0.50
    Hist Vol41.2%(High)

    Volume Flow

    VWAP$14.40
    OBV-9.6M
    AD Line-11.6M
    CMF (20d)-0.059

    Volume Metrics

    Avg Vol (20d)294.6K
    Vol Ratio1.5x
    VWMA (20d)$14.84

    Pivot Points

    R3$15.71
    R2$15.46
    R1$15.05
    Pivot Point$14.79
    S1$14.38
    S2$14.13
    S3$13.72

    Advanced Oscillators

    TSI-16.10
    Ultimate Osc32.9
    KST-77.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$29.13M$24.99M$20.73M$20.56M$24.16M$19.78M$15.10M$11.20M$7.77M$3.14M$539,000$434,000
    Cost of Revenue$2.98M$3.74M$3.01M$2.62M$3.32M$2.85M$2.13M$1.64M$1.52M$903,000$171,000$133,000
    Gross Profit$26.15M$21.26M$17.72M$17.94M$20.84M$16.94M$12.97M$9.56M$6.25M$2.24M$368,000$301,000
    Operating Expenses$23.75M$22.89M$19.90M$18.33M$18.25M$16.30M$9.94M$10.82M$10.16M$12.51M$11.67M$10.86M
    R&D$10.38M$9.82M$9.37M$7.99M$6.88M$5.01M$2.91M$3.87M$3.39M$3.70M$4.71M$4.66M
    SG&A$13.37M$13.07M$10.53M$10.34M$11.37M$11.29M$7.02M$6.95M$6.76M$8.81M$6.96M$6.20M
    Operating Income$2.40M$-1,637,000$-2,184,000$-388,000$2.59M$642,000$3.04M$-1,259,000$-3,912,000$-10,278,000$-11,304,000$-10,556,000
    Interest Income$781,000$787,000$857,000$796,000$649,000$618,000$295,000$113,000$-84,000$-199,000$15,000$-395,000
    Interest Expense$0$0$0$0$0$0$6.44M$0$9.83M$833,000$0$9.78M
    Income Before Tax$3.16M$-908,000$-1,334,000$375,000$3.21M$1.26M$-3,398,000$1.86M$-13,741,000$-11,111,000$-11,063,000$-20,335,000
    Income Tax Expense$491,000$162,000$562,000$-455,000$508,000$195,000$0$0$0$0$0$0
    Net Income$2.67M$-1,070,000$-1,896,000$830,000$2.70M$1.07M$-3,398,000$1.86M$-13,741,000$-11,111,000$-11,136,000$-20,340,000
    EBITDA$2.11M$-2,004,000$-2,536,000$-802,000$2.18M$407,000$-3,773,000$1.75M$-13,574,000$-10,816,000$-10,723,000$-19,718,000
    EBIT$2.38M$-1,695,000$-2,187,000$-421,000$2.56M$646,000$-3,705,000$1.75M$-13,667,000$-10,890,000$-11,078,000$-19,940,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DCTH

    News

    Delcath Systems Q2 Earnings Call Highlights

    Delcath Systems reported strong second-quarter 2026 results, with revenue up 20% to $29.1 million, driven by a 21% increase in HEPZATO KIT sales. The company raised its full-year revenue outlook to $104 million to $108...

    TradingView•10/30/26•Bullish

    BlackRock reports a passive stake above 5% in Delcath Systems (DCTH).

    BlackRock Portfolio Management LLC has reported a passive beneficial ownership of 2,180,493 shares, or 6.3% of the class, in Delcath Systems, Inc. (DCTH) as of September 30...

    Stock Titan•10/27/26•Neutral

    Delcath Systems to Participate in Upcoming Investor Conferences

    Delcath Systems, Inc. announced its participation in three upcoming investor conferences in November 2026: the UBS Global Healthcare Conference, Canaccord Genuity's MedTech...

    Yahoo Finance Singapore•10/27/26•Somewhat-Bullish

    Delcath Systems to Host Third Quarter 2026 Earnings Call

    Delcath Systems, Inc. announced it will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss its third-quarter 2026 financial results. The call will cover results for the quarter ended September...

    StreetInsider•10/27/26•Neutral

    Delcath Systems to Host Third Quarter 2026 Earnings Call

    Delcath Systems, Inc. announced it will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss its financial results for the third quarter ended September 30...

    Yahoo Finance•10/26/26•Neutral

    DCTH Valuation and Fair Value

    P/E
    1404.0x
    Forward P/E
    200.0x
    P/FCF
    28.8x
    PEG
    1.6x
    P/B
    4.2x
    See GNG's fair value

    DCTH Profitability: Margins, ROIC and FCF

    Gross margin
    87.1%
    Operating margin
    8.2%
    Net margin
    0.6%
    ROE
    0.5%
    FCF yield
    3.5%

    DCTH Competitors

    CompanyTicker
    DiaMedica Therapeutics IncDMAC
    Evolus IncEOLS
    CytomX Therapeutics IncCTMX
    Avita Medical LtdRCEL
    Ovid Therapeutics IncOVID
    Gyre Therapeutics Inc.GYRE
    AngioDynamics IncANGO
    Evolent Health IncEVH

    Sector: Healthcare

    DCTH Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    DCTH Bull Case vs Bear Case

    Bull case

    • DCTH beat EPS estimates in 87.5% of its last 8 reported quarters.
    • DCTH grew quarterly revenue 20.6% year over year.
    • 100.0% of DCTH's analyst ratings are Buy or Strong Buy.

    Bear case

    • DCTH trades at 1404.0x trailing earnings.

    DCTH Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    -71.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.07
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About DCTH

    Does DCTH pay dividends?

    Delcath Systems Inc (DCTH) does not currently pay a regular dividend.

    What is DCTH's P/E ratio?

    Delcath Systems Inc has a price-to-earnings (P/E) ratio of 1404.00.

    What is DCTH's market cap?

    Delcath Systems Inc (DCTH) has a market capitalization of $487.17M with a current stock price of $14.04.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In